tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Cannabis'

New Age Farm Inc. Growing Fundamentals with Revenue-Producing Portfolio in U.S., Canada, and South American Cannabis Markets

New Age Farm Inc. Growing Fundamentals with Revenue-Producing Portfolio in U.S., Canada, and South American Cannabis Markets

Written by Ι Stock Market Media — October 11, 2018

New Age Farm Inc. (OTC Markets: NWGFF) (CSE: NF) (FSE: 0NF) is growing quickly in the Cannabis industry, and it’s doing so by focusing on the fundamentals.  The Denver-based company is meticulously carving out its share of the emerging hemp and CBD markets in the U.S., Canada and South America. And, in the process, it’s providing the cannabis space with more choices while offering investors an opportunity to get in on the ...

Read More →
0

PUF Ventures Bringing Science of Plant Propagation to Medical and Recreational Cannabis Industry

PUF Ventures (CNW Group/PUF Ventures)

Written by Ι Stock Market Media — July 31, 2018

In an effort to differentiate itself from the emerging cannabis market in Canada, PUF Ventures Inc. (OTCPK: PUFXF) (CSE: PUF) (Frankfurt: PU3) has taken a novel approach to producing cannabis that should prove to be every bit as lucrative as growing it. With the idea of separating itself from the competition in mind, the innovative Vancouver-based company partnered with Casey Houweling, who has 4 decades of experience with plant propagation, to form ...

Read More →
0

BLOX Labs Using Blockchain Technology to Compete in Canada’s Cannabis Industry with Supply Chain Management Platform

BLOX Labs Using Blockchain Technology to Compete in Canada’s Cannabis Industry with Supply Chain Management Platform

Written by Ι Stock Market Media — July 11, 2018

BLOX Labs Inc. (OTCMKTS: BLLXF) (CSE: BLOX) (Frankfurt: BR1B), a Toronto-based technology development company focused on creating best-in-class software solutions driven by emerging trends in blockchain, smart contracts and decentralized apps, has ideally positioned itself to be a player in Canada’s legal cannabis industry. It’s an industry that just got a huge shot in the arm with last month’s legalization of marijuana nationwide. In Canada, marijuana possession, home growing, and sales of ...

Read More →
0

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Nuvilex, Inc. (OTCQB: NVLX) isn’t letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research.  The company is currently engaged in preclinical studies at the University of Northern Colorado (UNC) targeting Cannabis-based cancer treatments using Nuvilex’s Cell-in-a-Box® cellulose-based live cell encapsulation technology. 

While waiting for a Schedule 1 license from the DEA in order to conduct research using marijuana, Dr. ...

Read More →
0

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

Plandai Biotechnology Receives Approval to Grow Cannabis for Medical Research from Uruguay’s Minister of Public Health

SEATTLE, WA — October 29, 2014 — Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), a developer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that Uruguay’s Ministry of Public Health has approved an academic collaboration between Plandaí and the Group of Medicinal Chemistry from the School of Science at the University of the Republic (“University”) in Montevideo, Uruguay.  The approval, issued in September 2014, allows Plandaí to grow cannabis in conjunction with ...

Read More →
0

Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box Treatment for Pancreatic Cancer

Silver Spring, MD — October 13, 2014 — Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced today that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Orphan Drug Designation for its Cell-in-a-Box® treatment for pancreatic cancer. If granted, Orphan Drug Designation in the United States will provide Nuvilex special development and commercial assistance from the FDA, including a 7 year period of marketing exclusivity. ...

Read More →
0
Page 1 of 4 1234
ContactUs.com